These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD. Katz PO Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654 [TBL] [Abstract][Full Text] [Related]
4. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable? Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927 [TBL] [Abstract][Full Text] [Related]
5. Treatment of gastroesophageal reflux: the role of proton pump inhibitors. Schulman MI; Orlando RC Adv Intern Med; 1995; 40():273-302. PubMed ID: 7747649 [No Abstract] [Full Text] [Related]
6. Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment. Xue Y; Zhou LY; Lin SR Chin Med J (Engl); 2008 Jul; 121(14):1297-301. PubMed ID: 18713551 [TBL] [Abstract][Full Text] [Related]
8. Dexlansoprazole (Kapidex) for GERD and erosive esophagitis. Med Lett Drugs Ther; 2009 Mar; 51(1308):21-2. PubMed ID: 19305367 [No Abstract] [Full Text] [Related]
9. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group. Festen HP; Schenk E; Tan G; Snel P; Nelis F Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459 [TBL] [Abstract][Full Text] [Related]
10. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study. Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986 [TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451 [TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy. Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066 [TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori and omeprazole therapy in GERD. Kuipers EJ; Schenk BE; Klinkenberg-Knol EC; Meuwissen SG Am J Gastroenterol; 1999 Nov; 94(11):3378-9. PubMed ID: 10566757 [No Abstract] [Full Text] [Related]
14. [Lansoprazol]. Ponce J; Nos P Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274 [No Abstract] [Full Text] [Related]
15. [Heartburn. Only a harmless symptom?]. MMW Fortschr Med; 2001 Mar; 143(10):45. PubMed ID: 11277116 [No Abstract] [Full Text] [Related]
16. [Successful treatment of severe reflux esophagitis with omeprazole: a therapeutic success?]. Müller-Lissner S Z Gastroenterol; 1989 Feb; 27(2):131-2. PubMed ID: 2658391 [No Abstract] [Full Text] [Related]